Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("JANUZZI, James L")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 138

  • Page / 6
Export

Selection :

  • and

The role of natriuretic peptide testing in guiding chronic heart failure management: Review of available data and recommendations for useJANUZZI, James L.Archives of cardiovascular diseases. 2012, Vol 105, Num 1, pp 40-50, issn 1875-2136, 11 p.Article

Are Serial BNP Measurements Useful in Heart Failure Management?: Serial Natriuretic Peptide Measurements Are Useful in Heart Failure ManagementJANUZZI, James L; TROUGHTON, Richard.Circulation (New York, N.Y.). 2013, Vol 127, Num 4, pp 500-507, issn 0009-7322, 8 p.Article

Natriuretic Peptide Testing in Heart FailureKIM, Han-Na; JANUZZI, James L.Circulation (New York, N.Y.). 2011, Vol 123, Num 18, pp 2015-2019, issn 0009-7322, 5 p.Article

ST-Elevation Alternans and Nonsustained Polymorphic Ventricular Tachycardia in a Patient With Prinzmetal (Variant) AnginaSHAH, Ravi V; JANUZZI, James L.Circulation (New York, N.Y.). 2010, Vol 121, Num 11, pp 1371-1373, issn 0009-7322, 3 p.Article

Non-ST segment elevation acute coronary syndromes : A comprehensive reviewMARTINEZ-RUMAYOR, Abelardo; JANUZZI, James L.Southern medical journal (Birmingham). 2006, Vol 99, Num 10, pp 1103-1110, issn 0038-4348, 8 p.Article

Association between C-reactive protein and generalized anxiety disorder in stable coronary heart disease patientsBANKIER, Bettina; BARAJAS, Justine; MARTINEZ-RUMAYOR, Abelardo et al.European heart journal. 2008, Vol 29, Num 18, pp 2212-2217, issn 0195-668X, 6 p.Article

Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure SectionJANUZZI, James L; FILIPPATOS, Gerasimos; NIEMINEN, Markku et al.European heart journal. 2012, Vol 33, Num 18, pp 2265-2271, issn 0195-668X, 7 p.Article

Peripheral arterial disease, acute coronary syndromes, and early invasive management : The TACTICS TIMI 18 trialJANUZZI, James L; BUROS, Jacqueline; CANNON, Christopher P et al.Clinical cardiology (Mahwah, NJ). 2005, Vol 28, Num 5, pp 238-242, issn 0160-9289, 5 p.Article

When Cardiac Failure, Kidney Dysfunction, and Kidney Injury Intersect in Acute Conditions: The Case of Cardiorenal SyndromeLEGRAND, Matthieu; MEBAZAA, Alexandre; RONCO, Claudio et al.Critical care medicine. 2014, Vol 42, Num 9, pp 2109-2117, issn 0090-3493, 9 p.Article

Increases of Cardiac Troponin in Conditions other than Acute Coronary Syndrome and Heart FailureKELLEY, Walter E; JANUZZI, James L; CHRISTENSON, Robert H et al.Clinical chemistry (Baltimore, Md.). 2009, Vol 55, Num 12, pp 2098-2112, issn 0009-9147, 15 p.Article

Association Between Anxiety and C-Reactive Protein Levels in Stable Coronary Heart Disease PatientsBANKIER, Bettina; ABELARDO MARTINEZ-RUMAYOR, Justine Barajas; JANUZZI, James L et al.Psychosomatics (Washington, DC). 2009, Vol 50, Num 4, pp 347-353, issn 0033-3182, 7 p.Article

Association between major depressive disorder and C-reactive protein levels in stable coronary heart disease patientsBANKIER, Bettina; BARAJAS, Justine; MARTINEZ-RUMAYOR, Abelardo et al.Journal of psychosomatic research. 2009, Vol 66, Num 3, pp 189-194, issn 0022-3999, 6 p.Article

Characteristics of the Novel Interleukin Family Biomarker ST2 in Patients With Acute Heart Failure. CommentaryREHMAN, Shafiq U; MUELLER, Thomas; JANUZZI, James L et al.Journal of the American College of Cardiology. 2008, Vol 52, Num 18, pp 1458-1467, issn 0735-1097, 10 p.Article

Triggers of acute coronary syndromes : Unstable plaque, Part ISERVOSS, Stephen J; JANUZZI, James L; MULLER, James E et al.Progress in cardiovascular diseases. 2002, Vol 44, Num 5, pp 369-380, issn 0033-0620Article

Fundamental concepts in the pathobiology of heparin-induced thrombocytopeniaJANUZZI, James L; JANG, Ik-Kyung.Journal of thrombosis and thrombolysis. 2000, Vol 10, pp S7-S11, issn 0929-5305, SUP1Article

Usefulness of Natriuretic Peptide Testing for Long-Term Risk Assessment Following Acute Ischemic StrokeJENSEN, Jesper K; ATAR, Dan; KRISTENSEN, Søren R et al.The American journal of cardiology. 2009, Vol 104, Num 2, pp 287-291, issn 0002-9149, 5 p.Article

Benefits and safety of tirofiban among acute coronary Syndrome patients with mild to moderate renal insufficiency: Results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in patients limited by Unstable Signs and Symptoms (PRISM-PLUS) trialJANUZZI, James L; SNAPINN, Steven M; DIBATTISTE, Peter M et al.Circulation (New York, N.Y.). 2002, Vol 105, Num 20, pp 2361-2366, issn 0009-7322Article

Cost-effectiveness of using N-terminal pro-brain natriuretic peptide to guide the diagnostic assessment and management of dyspneic patients in the emergency departmenSIEBERT, Uwe; JANUZZI, James L; BEINFELD, Molly T et al.The American journal of cardiology. 2006, Vol 98, Num 6, pp 800-805, issn 0002-9149, 6 p.Article

Ischemia-modified albumin improves the usefulness of standard cardiac biomarkers for the diagnosis of myocardial ischemia in the emergency department settingANWARUDDIN, Saif; JANUZZI, James L; BAGGISH, Aaron L et al.American journal of clinical pathology. 2005, Vol 123, Num 1, pp 140-145, issn 0002-9173, 6 p.Article

Positive predictive value of a point-of-care testing strategy on first-draw specimens for the emergency department-based detection of acute coronary syndromesKRATZ, Alexander; JANUZZI, James L; LEWANDROWSKI, Kent B et al.Archives of pathology & laboratory medicine (1976). 2002, Vol 126, Num 12, pp 1487-1493, issn 0363-0153, 7 p.Article

Elevation in serum troponin I predicts the benefit of tirofibanJANUZZI, James L; CHAE, Claudia U; SABATINE, Marc S et al.Journal of thrombosis and thrombolysis. 2001, Vol 11, Num 3, pp 211-215, issn 0929-5305Article

Inflammatory Markers, Amino-Terminal Pro-Brain Natriuretic Peptide, and Mortality Risk in Dyspneic PatientsREHMAN, Shafiq; LLOYD-JONES, Donald M; MARTINEZ-RUMAYOR, Abelardo et al.American journal of clinical pathology. 2008, Vol 130, Num 2, pp 305-311, issn 0002-9173, 7 p.Article

Reevaluation of myoglobin for acute chest pain evaluation: Would false-positive results on first-draw specimens lead to increased hospital admissions?MELANSON, Stacy Foran; LEWANDROWSKI, Elizabeth Lee; JANUZZI, James L et al.American journal of clinical pathology. 2004, Vol 121, Num 6, pp 804-808, issn 0002-9173, 5 p.Article

Optimizing glycoprotein IIb/IIIa receptor antagonist use for the non-ST-segment elevation acute coronary syndromes: Risk stratification and therapeutic interventionJANUZZI, James L; CANNON, Christopher P; THEROUX, Pierre et al.The American heart journal. 2003, Vol 146, Num 5, pp 764-774, issn 0002-8703, 11 p.Article

Comparison of cardiac marker concentrations in healthy blood donors and hospital patients without acute coronary syndromeKRATZ, Alexander; LEWANDROWSKI, Kent B; JANUZZI, James L et al.The American journal of cardiology. 2003, Vol 90, Num 2, pp 177-178, issn 0002-9149Article

  • Page / 6